# Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)

> **NCT01716533** · NA · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 57 (actual)

## Conditions studied

- Infections, Clostridium Difficile

## Interventions

- **PROCEDURE:** Blood sampling
- **OTHER:** Stool sample collection

## Key facts

- **NCT ID:** NCT01716533
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-02
- **Primary completion:** 2015-06-01
- **Final completion:** 2015-06-01
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2019-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01716533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01716533, "Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01716533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*